Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study.

Rasche L, Scheel M, Otte K, Althoff P, van Vuuren AB, Gieß RM, Kuchling J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU, Schmitz-Hübsch T.

Front Neurol. 2018 Aug 29;9:718. doi: 10.3389/fneur.2018.00718. eCollection 2018.

2.

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders.

Asseyer S, Schmidt F, Chien C, Scheel M, Ruprecht K, Bellmann-Strobl J, Brandt AU, Paul F.

Mult Scler J Exp Transl Clin. 2018 Aug 30;4(3):2055217318796684. doi: 10.1177/2055217318796684. eCollection 2018 Jul-Sep.

3.

Temporal visual resolution and disease severity in MS.

Ayadi N, Dörr J, Motamedi S, Gawlik K, Bellmann-Strobl J, Mikolajczak J, Brandt AU, Zimmermann H, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 14;5(5):e492. doi: 10.1212/NXI.0000000000000492. eCollection 2018 Sep.

4.

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.

Behrens JR, Wanner J, Kuchling J, Ostendorf L, Harms L, Ruprecht K, Niendorf T, Jarius S, Wildemann B, Gieß RM, Scheel M, Bellmann-Strobl J, Wuerfel J, Paul F, Sinnecker T.

Ann Clin Transl Neurol. 2018 Jun 29;5(8):900-912. doi: 10.1002/acn3.572. eCollection 2018 Aug.

5.

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.

Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M.

Neuroimage Clin. 2018 May 8;19:538-550. doi: 10.1016/j.nicl.2018.05.004. eCollection 2018.

6.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2018 Jun 19. pii: jnnp-2018-318382. doi: 10.1136/jnnp-2018-318382. [Epub ahead of print]

PMID:
29921610
7.

MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.

Chien C, Brandt AU, Schmidt F, Bellmann-Strobl J, Ruprecht K, Paul F, Scheel M.

AJNR Am J Neuroradiol. 2018 Jul;39(7):1362-1368. doi: 10.3174/ajnr.A5665. Epub 2018 May 10.

PMID:
29748202
8.

Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.

Zimmermann HG, Knier B, Oberwahrenbrock T, Behrens J, Pfuhl C, Aly L, Kaminski M, Hoshi MM, Specovius S, Giess RM, Scheel M, Mühlau M, Bellmann-Strobl J, Ruprecht K, Hemmer B, Korn T, Paul F, Brandt AU.

JAMA Neurol. 2018 Sep 1;75(9):1071-1079. doi: 10.1001/jamaneurol.2018.1011.

PMID:
29710121
9.

Multiple sclerosis-related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.

Jaeger S, Paul F, Scheel M, Brandt A, Heine J, Pach D, Witt CM, Bellmann-Strobl J, Finke C.

Mult Scler. 2018 Feb 1:1352458518758911. doi: 10.1177/1352458518758911. [Epub ahead of print]

10.

Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.

Backner Y, Kuchling J, Massarwa S, Oberwahrenbrock T, Finke C, Bellmann-Strobl J, Ruprecht K, Brandt AU, Zimmermann H, Raz N, Paul F, Levin N.

JAMA Neurol. 2018 Mar 1;75(3):287-295. doi: 10.1001/jamaneurol.2017.3880.

PMID:
29297053
11.

Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.

Finke C, Zimmermann H, Pache F, Oertel FC, Chavarro VS, Kramarenko Y, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

JAMA Neurol. 2018 Mar 1;75(3):296-303. doi: 10.1001/jamaneurol.2017.3890.

PMID:
29297041
12.

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.

Gaede G, Tiede M, Lorenz I, Brandt AU, Pfueller C, Dörr J, Bellmann-Strobl J, Piper SK, Roth Y, Zangen A, Schippling S, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 13;5(1):e423. doi: 10.1212/NXI.0000000000000423. eCollection 2018 Jan.

13.

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.

Grobelny A, Behrens JR, Mertens S, Otte K, Mansow-Model S, Krüger T, Gusho E, Bellmann-Strobl J, Paul F, Brandt AU, Schmitz-Hübsch T.

PLoS One. 2017 Dec 15;12(12):e0189281. doi: 10.1371/journal.pone.0189281. eCollection 2017.

14.

Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.

Höltje M, Mertens R, Schou MB, Saether SG, Kochova E, Jarius S, Prüss H, Komorowski L, Probst C, Paul F, Bellmann-Strobl J, Gitler D, Benfenati F, Piepgras J, Ahnert-Hilger G, Ruprecht K.

Brain Behav Immun. 2017 Nov;66:125-134. doi: 10.1016/j.bbi.2017.07.011. Epub 2017 Jul 18.

PMID:
28733081
15.

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.

Weygandt M, Wakonig K, Behrens J, Meyer-Arndt L, Söder E, Brandt AU, Bellmann-Strobl J, Ruprecht K, Gold SM, Haynes JD, Paul F.

Mult Scler. 2018 Aug;24(9):1163-1173. doi: 10.1177/1352458517717089. Epub 2017 Jun 28.

PMID:
28657480
16.

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.

Oertel FC, Zimmermann H, Mikolajczak J, Weinhold M, Kadas EM, Oberwahrenbrock T, Pache F, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 18;4(3):e338. doi: 10.1212/NXI.0000000000000338. eCollection 2017 May. No abstract available.

17.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Gieß RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

PLoS One. 2017 Apr 7;12(4):e0175279. doi: 10.1371/journal.pone.0175279. eCollection 2017.

18.

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.

Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 22;4(3):e334. doi: 10.1212/NXI.0000000000000334. eCollection 2017 May.

19.

Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.

Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Mult Scler Relat Disord. 2017 Jan;11:45-50. doi: 10.1016/j.msard.2016.11.008. Epub 2016 Nov 20.

PMID:
28104256
20.

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.

Krüger T, Behrens JR, Grobelny A, Otte K, Mansow-Model S, Kayser B, Bellmann-Strobl J, Brandt AU, Paul F, Schmitz-Hübsch T.

BMC Neurol. 2017 Jan 13;17(1):10. doi: 10.1186/s12883-016-0783-0.

21.

Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Weygandt M, Meyer-Arndt L, Behrens JR, Wakonig K, Bellmann-Strobl J, Ritter K, Scheel M, Brandt AU, Labadie C, Hetzer S, Gold SM, Paul F, Haynes JD.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13444-13449. Epub 2016 Nov 7.

22.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):281.

23.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):282.

24.

Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.

Brandt AU, Meinert-Bohn E, Rinnenthal JL, Zimmermann H, Mikolajczak J, Oberwahrenbrock T, Papazoglou S, Pfüller CF, Schinzel J, Tackenberg B, Paul F, Hahn K, Bellmann-Strobl J.

PLoS One. 2016 Oct 17;11(10):e0164617. doi: 10.1371/journal.pone.0164617. eCollection 2016.

25.

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.

Schlemm L, Chien C, Bellmann-Strobl J, Dörr J, Wuerfel J, Brandt AU, Paul F, Scheel M.

Mult Scler. 2017 Jun;23(7):963-972. doi: 10.1177/1352458516670738. Epub 2016 Sep 27.

PMID:
27679460
26.

Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.

Streitberger KJ, Fehlner A, Pache F, Lacheta A, Papazoglou S, Bellmann-Strobl J, Ruprecht K, Brandt A, Braun J, Sack I, Paul F, Wuerfel J.

Eur Radiol. 2017 May;27(5):2206-2215. doi: 10.1007/s00330-016-4561-6. Epub 2016 Aug 29.

PMID:
27572811
27.

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.

Schlemm L, Giess RM, Rasche L, Pfuhl C, Wakonig K, Behrens JR, Scheibenbogen C, Bellmann-Strobl J, Paul F, Reimer U, Ruprecht K.

J Neuroimmunol. 2016 Aug 15;297:56-62. doi: 10.1016/j.jneuroim.2016.05.012. Epub 2016 May 13.

PMID:
27397076
28.

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.

Finke C, Heine J, Pache F, Lacheta A, Borisow N, Kuchling J, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e229. doi: 10.1212/NXI.0000000000000229. eCollection 2016 Jun.

29.

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.

Schumacher S, Pache F, Bellmann-Strobl J, Behrens J, Dusek P, Harms L, Ruprecht K, Nytrova P, Chawla S, Niendorf T, Kister I, Paul F, Ge Y, Wuerfel J, Sinnecker T.

MAGMA. 2016 Jun;29(3):535-41. doi: 10.1007/s10334-016-0554-3. Epub 2016 Apr 12.

PMID:
27072685
30.

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.

Rasche L, Heiserich L, Behrens JR, Lenz K, Pfuhl C, Wakonig K, Gieß RM, Freitag E, Eberle C, Wuerfel J, Dörr J, Bauer P, Bellmann-Strobl J, Paul F, Roggenbuck D, Ruprecht K.

PLoS One. 2016 Jan 28;11(1):e0147968. doi: 10.1371/journal.pone.0147968. eCollection 2016.

31.

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.

Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM.

Mult Scler. 2016 Oct;22(11):1476-1484. Epub 2016 Jan 8.

PMID:
26746809
32.

Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.

Fehlner A, Behrens JR, Streitberger KJ, Papazoglou S, Braun J, Bellmann-Strobl J, Ruprecht K, Paul F, Würfel J, Sack I.

J Magn Reson Imaging. 2016 Jul;44(1):51-8. doi: 10.1002/jmri.25129. Epub 2015 Dec 30.

PMID:
26714969
33.

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.

Hertwig L, Pache F, Romero-Suarez S, Stürner KH, Borisow N, Behrens J, Bellmann-Strobl J, Seeger B, Asselborn N, Ruprecht K, Millward JM, Infante-Duarte C, Paul F.

Mult Scler. 2016 Feb;22(2):160-73. doi: 10.1177/1352458515586084. Epub 2015 Jun 25.

PMID:
26540731
34.

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.

Keller A, Leidinger P, Meese E, Haas J, Backes C, Rasche L, Behrens JR, Pfuhl C, Wakonig K, Gieß RM, Jarius S, Meder B, Bellmann-Strobl J, Paul F, Pache FC, Ruprecht K.

J Neuroinflammation. 2015 Oct 31;12:196. doi: 10.1186/s12974-015-0418-1.

35.

Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.

Mossakowski AA, Pohlan J, Bremer D, Lindquist R, Millward JM, Bock M, Pollok K, Mothes R, Viohl L, Radbruch M, Gerhard J, Bellmann-Strobl J, Behrens J, Infante-Duarte C, Mähler A, Boschmann M, Rinnenthal JL, Füchtemeier M, Herz J, Pache FC, Bardua M, Priller J, Hauser AE, Paul F, Niesner R, Radbruch H.

Acta Neuropathol. 2015 Dec;130(6):799-814. doi: 10.1007/s00401-015-1497-x. Epub 2015 Oct 31.

36.

Iridodonesis as a cause of recurrent vertigo.

Kunte H, Paul F, Pache F, Dörr J, Bellmann-Strobl J, Harms L, Kronenberg G.

Neurology. 2015 Oct 13;85(15):1353. doi: 10.1212/WNL.0000000000002025. No abstract available.

PMID:
26459941
37.

Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.

Behrens JR, Rasche L, Gieß RM, Pfuhl C, Wakonig K, Freitag E, Deuschle K, Bellmann-Strobl J, Paul F, Ruprecht K, Dörr J.

Eur J Neurol. 2016 Jan;23(1):62-7. doi: 10.1111/ene.12788. Epub 2015 Jul 28.

PMID:
26220765
38.

Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.

Pfuhl C, Oechtering J, Rasche L, Gieß RM, Behrens JR, Wakonig K, Freitag E, Pache FC, Otto C, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

J Neuroimmunol. 2015 Aug 15;285:156-60. doi: 10.1016/j.jneuroim.2015.06.012. Epub 2015 Jun 25.

PMID:
26198934
39.

Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.

Janssen A, Fiebiger S, Bros H, Hertwig L, Romero-Suarez S, Hamann I, Chanvillard C, Bellmann-Strobl J, Paul F, Millward JM, Infante-Duarte C.

PLoS One. 2015 Jun 26;10(6):e0130251. doi: 10.1371/journal.pone.0130251. eCollection 2015.

40.

Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers.

Gaede G, Hellweg R, Zimmermann H, Brandt AU, Dörr J, Bellmann-Strobl J, Zangen A, Paul F, Pfueller CF.

Neuropsychobiology. 2014;69(2):112-9. doi: 10.1159/000358088. Epub 2014 Mar 12.

PMID:
24643119
41.

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.

Wieder L, Gäde G, Pech LM, Zimmermann H, Wernecke KD, Dörr JM, Bellmann-Strobl J, Paul F, Brandt AU.

BMC Neurol. 2013 Nov 8;13:167. doi: 10.1186/1471-2377-13-167.

42.

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.

Derkow K, Bauer JM, Hecker M, Paap BK, Thamilarasan M, Koczan D, Schott E, Deuschle K, Bellmann-Strobl J, Paul F, Zettl UK, Ruprecht K, Lehnardt S.

PLoS One. 2013 Aug 12;8(8):e70626. doi: 10.1371/journal.pone.0070626. eCollection 2013.

43.

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.

Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, Bellmann-Strobl J, Harmel J, Ruprecht K, Schippling S, Hartung HP, Aktas O, Brandt AU, Paul F.

Mult Scler. 2013 Dec;19(14):1887-95. doi: 10.1177/1352458513489757. Epub 2013 May 23.

44.

Are there Epstein-Barr virus seronegative patients with multiple sclerosis?

Deuschle K, Hofmann J, Otto C, Bellmann-Strobl J, Scherner O, Klumbies K, Schneider E, Broddack J, Paul F, Ruprecht K.

Mult Scler. 2013 Aug;19(9):1242-3. doi: 10.1177/1352458512472751. Epub 2013 Jan 10. No abstract available.

PMID:
23307904
45.

Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?

Hackmack K, Weygandt M, Wuerfel J, Pfueller CF, Bellmann-Strobl J, Paul F, Haynes JD.

J Neurol. 2012 Oct;259(10):2151-60. doi: 10.1007/s00415-012-6475-9. Epub 2012 Mar 24.

PMID:
22446893
46.

MRI pattern recognition in multiple sclerosis normal-appearing brain areas.

Weygandt M, Hackmack K, Pfüller C, Bellmann-Strobl J, Paul F, Zipp F, Haynes JD.

PLoS One. 2011;6(6):e21138. doi: 10.1371/journal.pone.0021138. Epub 2011 Jun 17.

47.

Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis.

Pfueller CF, Brandt AU, Schubert F, Bock M, Walaszek B, Waiczies H, Schwenteck T, Dörr J, Bellmann-Strobl J, Mohr C, Weinges-Evers N, Ittermann B, Wuerfel JT, Paul F.

PLoS One. 2011 Apr 6;6(4):e18019. doi: 10.1371/journal.pone.0018019.

48.

Association of retinal and macular damage with brain atrophy in multiple sclerosis.

Dörr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU, Friedemann P.

PLoS One. 2011 Apr 8;6(4):e18132. doi: 10.1371/journal.pone.0018132.

49.

Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis.

Bock M, Brandt AU, Kuchenbecker J, Dörr J, Pfueller CF, Weinges-Evers N, Gaede G, Zimmermann H, Bellmann-Strobl J, Ohlraun S, Zipp F, Paul F.

Br J Ophthalmol. 2012 Jan;96(1):62-7. doi: 10.1136/bjo.2010.193581. Epub 2011 Mar 3.

PMID:
21378002
50.

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.

Veauthier C, Radbruch H, Gaede G, Pfueller CF, Dörr J, Bellmann-Strobl J, Wernecke KD, Zipp F, Paul F, Sieb JP.

Mult Scler. 2011 May;17(5):613-22. doi: 10.1177/1352458510393772. Epub 2011 Jan 28.

PMID:
21278050

Supplemental Content

Loading ...
Support Center